Katie L Harrigan

US Patent:

20110152196, Jun 23, 2011

Filed:

Jan 3, 2011

Appl. No.:

12/983350

Inventors:

Bhavin Shah - West Lafayette IN, US
Katie L. Harrigan - Cordova TN, US

International Classification:

A61K 38/39

US Classification:

514 172

Abstract:

Described are purified extracellular matrix materials isolated from the abdominal wall of animals and including the subserous fascia layer of the abdominal wall. Such medical materials can find use in treating damaged tissue and in certain aspects in providing tissue support for the repair of hernias. Related methods of manufacture and use are also described.

US Patent:

20130310322, Nov 21, 2013

Filed:

Jul 26, 2013

Appl. No.:

13/951631

Inventors:

Katie L. Harrigan - Lafayette IN, US

International Classification:

A61K 38/39

US Classification:

514 172

Abstract:

Described are purified extracellular matrix materials isolated from the abdominal wall of animals and including the subserous fascia layer of the abdominal wall. Such medical materials can find use in treating damaged tissue and in certain aspects in providing tissue support for the repair of hernias. Related methods of manufacture and use are also described.

US Patent:

20210220514, Jul 22, 2021

Filed:

Mar 31, 2021

Appl. No.:

17/219763

Inventors:

- Rockville MD, US
Jamie MacDougall - Oakland TN, US
Katie Harrigan - Cordova TN, US

Assignee:

Agnovos Healthcare, LLC - Rockville MD

International Classification:

A61L 27/12
C04B 28/34
A61L 24/02
A61L 27/02
A61L 27/36
A61L 27/54
A61L 27/56
A61L 27/58
A61L 24/00
C04B 28/14
A61L 27/38

Abstract:

Disclosed are kits for preparing a reactive graft material and injecting the graft material into a patient. Kits may include a first syringe containing a first powdered component and a second syringe containing a second powdered component that is reactive with the first powdered component when the first and second powdered components are dispersed in a diluent solution. The kits may further include a vial sealed by a septum and containing the diluent solution. A syringe connector may be included that has a connector at each end configured to make a fluidic connection to, respectively, the first syringe and the second syringe, and also comprises a passageway adapted to allow fluid to pass between the syringes when the syringes are both fluidically connected to the syringe connector. A vial adapter comprising a connector adapted for fluidically connecting to at least one of the first syringe and the second syringe, a passageway adapted to allow fluid to pass from the vial into a syringe fluidically connected to the connector of the vial adapter, and a spike in fluidic communication with the passageway of the vial adapter may be included. The spike is adapted for piercing the septum of the vial. Certain kits also contain one or more needles for delivery of the graft material to a site within a body of a patient.

US Patent:

20160354514, Dec 8, 2016

Filed:

Aug 16, 2016

Appl. No.:

15/238130

Inventors:

- Rockville MD, US
Jamie MacDougall - Oakland TN, US
Katie Harrigan - Cordova TN, US

Assignee:

Agnovos Healthcare, LLC - Rockville MD

International Classification:

A61L 27/12
A61L 27/38
A61L 27/54
A61L 27/02
A61L 27/56

Abstract:

The invention provides a particulate composition adapted for forming a bone graft substitute cement upon mixing with an aqueous solution, comprising i) a calcium sulfate hemihydrate powder, wherein the calcium sulfate hemihydrate is present at a concentration of at least about 50 weight percent based on the total weight of the particulate composition; ii) a monocalcium phosphate monohydrate powder; iii) a non-porous β-tricalcium phosphate powder; and iv) a porous β-tricalcium phosphate powder. Bone graft substitute cements made therefrom, a bone graft substitute kit comprising the particulate composition, methods of making and using the particulate composition, and articles made from the bone graft substitute cement are also provided.

US Patent:

20160303276, Oct 20, 2016

Filed:

Dec 12, 2014

Appl. No.:

15/103860

Inventors:

- Memphis TN, US
Jamie Macdougall - Oakland TN, US
Katie Harrigan - Cordova TN, US

Assignee:

Wright Medical Technology, Inc. - Memphis TN

International Classification:

A61L 24/02
C04B 28/14
A61L 24/00
C04B 28/34

Abstract:

The invention provides a particulate composition adapted for forming a bone graft substitute cement upon mixing with an aqueous solution, comprising i) a calcium sulfate hemihydrate powder, wherein the calcium sulfate hemihydrate is present at a concentration of at least about 50 weight percent based on the total weight of the particulate composition; ii) a monocalcium phosphate monohydrate powder; iii) a non-porous β-tricalcium phosphate powder; and iv) a porous β-tricalcium phosphate powder. Bone graft substitute cements made therefrom, a bone graft substitute kit comprising the particulate composition, methods of making and using the particulate composition, and articles made from the bone graft substitute cement are also provided.

US Patent:

20150196689, Jul 16, 2015

Filed:

Dec 12, 2014

Appl. No.:

14/568773

Inventors:

Jon Moseley - Arlington TN, US
Jamie Macdougall - Oakland TN, US
Katie Harrigan - Cordova TN, US

International Classification:

A61L 27/58
A61L 27/12
A61L 27/56
A61L 27/02
A61L 27/36
A61L 27/54

Abstract:

The invention provides a particulate composition adapted for forming a bone graft substitute cement upon mixing with an aqueous solution, comprising i) a calcium sulfate hemihydrate powder, wherein the calcium sulfate hemihydrate is present at a concentration of at least about 50 weight percent based on the total weight of the particulate composition; ii) a monocalcium phosphate monohydrate powder; iii) a non-porous β-tricalcium phosphate powder; and iv) a porous β-tricalcium phosphate powder. Bone graft substitute cements made therefrom, a bone graft substitute kit comprising the particulate composition, methods of making and using the particulate composition, and articles made from the bone graft substitute cement are also provided.